A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Konstas A.G.; Garhöfer G.; Lübke Y.; Voykov B.; Ropo A.
As a specialist with over 130 years of expertise, Santen is committed to continually investigating the latest in science and innovation to deliver the best vision experience.
About Publications PlusTherapeutic Area
Technology
Category
Konstas A.G.; Garhöfer G.; Lübke Y.; Voykov B.; Ropo A.
Lo P.F.; Gunawan M.; Yap Z.L.; Leong C.; Kwek F.; Varadarajan J.; Wang X.; Kageyama M.; Wong T.T.
Groth S.L.; Newcomb C.W.; Yang W.; Payal A.; Begum H.; Khachatryan N.; Kaçmaz R.O.; Dreger K.A.; Rosenbaum J.T.; Nida Sen H.; Suhler E.B.; Thorne J.E.; Bhatt N.P.; Foster C.S.; Jabs D.A.; Levy-Clarke G.A.; Buchanich J.M.; Ying G.S.; Kempen J.H.; Gangaputra S.;
Document number: NP-No product-EMEA-0110
Date of preparation: February 2022